Risedronate sodium
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Risedronate Sodium is a generic bisphosphonate medication used to treat and prevent osteoporosis by strengthening bones. It comes as a 35 mg delayed-release oral tablet, manufactured by Sun Pharmaceutical Industries Inc. under ANDA203925. This product is discontinued. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Risedronate sodium
Access the FDA dataset for Risedronate sodium — ANDA 203925 submitted by Mylan Institutional LLC
Modified Apr 29, 2026